Study Shows Novel sa-mRNA Vaccines Offer Robust, Broad, Enduring Protection Against COVID-19 Variants

Arcturus Therapeutics Holdings Inc. (the “Company”, “Arcturus”, Nasdaq: ARCT), a global late-stage clinical messenger RNA medicines...

September 20, 2023 | Wednesday | News
Evaxion Expands Bacterial Vaccine Pipeline in Pharma Collaboration

AI-powered target discovery for a bacterial pathogen with a high medical need where no vaccine is currently available  Evaxion’s proprietary ...

September 19, 2023 | Tuesday | News
FDA Acts on Updated mRNA COVID-19 Vaccines for Variant Protection

What You Need to Know Individuals 5 years of age and older regardless of previous vaccination are eligible to receive a single dose of an updated mRNA C...

September 12, 2023 | Tuesday | News
Clover Launches Quadrivalent Seasonal Influenza Vaccine in Mainland China

Second commercialized product strengthens Clover’s leading respiratory vaccine franchise and financial profile--   Clover Biopharmaceutica...

September 12, 2023 | Tuesday | News
Novozymes and Bactolife Partner to Cut Weaner Pig Antibiotic Use

Novozymes and the Danish industrial biotech company, Bactolife, have signed a joint development and commercialization agreement to finish development and l...

September 05, 2023 | Tuesday | News
Pfizer-BioNTech's Omicron-adapted COVID-19 Vaccine Gets Positive CHMP Opinion in EU

 The updated COVID-19 vaccine is tailored to the Omicron XBB.1.5 sublineage of SARS-CoV-2 and is recommended for individuals 6 months of age a...

September 04, 2023 | Monday | News
EU Approves Roche's Evrysdi for Infants Under Two Months with SMA

Evrysdi available to treat people of all ages with SMA in the European Union, including babies from birth1 Approval is based on interim data from ongoin...

August 29, 2023 | Tuesday | News
FDA Approves Veklury® for Hepatic Impairment COVID-19 Treatment

Gilead Sciences, Inc. (Nasdaq: GILD)  announced that the U.S. Food and Drug Administration (FDA) approved a supplemental new drug application (sNDA) f...

August 25, 2023 | Friday | News
IMUNON Collaborates for Preclinical Lassa Virus Vaccine Study

IMUNON, Inc. (NASDAQ: IMNN), a clinical-stage biotechnology company, announces it has entered into a Cooperative Research and Development Agreement (CRADA)...

August 25, 2023 | Friday | News
SK Bioscience, Vaxxas Partner for Needle-Free Typhoid Vaccine Patch

The HD-MAP platform technology offers user-friendly vaccines, allowing possible self-administration. Its room temperature stability revolutionizes distri...

August 24, 2023 | Thursday | News
Twist Bioscience Releases 2023 ESG Report and Quantifies Carbon Footprint of Manufacturing a Single Gene

“We took a big step forward in our ongoing commitment to deliver sustainable solutions to our customers, quantifying the impact of our proprietary ap...

August 23, 2023 | Wednesday | Reports
FDA Approves First Vaccine for Pregnant Individuals to Prevent RSV in Infants

Abrysvo is administered as a single dose injection into the muscle. The FDA approved Abrysvo in May for the prevention of LRTD caused by RSV in individuals...

August 22, 2023 | Tuesday | News
Arcturus Therapeutics Partner ARCALIS Gets $115M Grants from Japan

LUNAR-FLU collaboration with CSL Seqirus achieves additional $17.5 million development milestone   Arcturus Therapeutics Holdings Inc. (the “C...

August 15, 2023 | Tuesday | News
Bavarian Nordic's Chikungunya Vaccine Shows Positive Phase 3 Results in Adults and Adolescents

Chikungunya vaccine candidate met all the co-primary endpoints of the Phase 3 study and was shown to be highly immunogenic in the majority of subjects 22...

August 07, 2023 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2023 Biopharma Boardroom. All Rights Reserved.


Forgot your password?



Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in